The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...
For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...
"They didn't value me as much," the actress says of initially not having the same name recognition as her male co-star The ...
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
A new study conducted by researchers from the Washington University School of Medicine identified an experimental drug that ...
An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.
PathChat, a new AI model for pathology made by Modella AI, received breakthrough status in January. The device can digest ...
The results boost hopes similar treatments being developed to target more common forms of Alzheimer’s – that appear when ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback